| Company Name | Daiichi Sankyo Taiwan |
|---|---|
| Protocol Number | DU176b-D-A4010 |
| Title of Study | Non-Interventional Study on Edoxaban Treatment in Routine Clinical Practice in Patients with Venous Thromboembolism in Korea and Taiwan |
| Primary Objective | Primary objective is the analysis of the overall symptomatic VTE recurrence rate during an overall observational period of 12 months in unselected patients with acute VTE. |
| Number of Sites | 10 |
| Period of Study | From：04/05/2017 to：06/2020 |
| Number of Patients | 150人 |
| IRB Approval Date | 01/08/2017 |
| Publication Plan / Date | TBC |
